Volume | 455,708 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 0.43 | Mínimo Máximo |
|||||
Minimo del Dia | 0.3658 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Aligos Therapeutics Inc | ALGS | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
0.3952 | 0.3658 | 0.43 | 0.3784 | 0.3986 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
727 | 455,708 | US$ 0.3948981 | US$ 179,958 | - | 0.3658 - 1.20 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
15:00:00 | 1,328 | US$ 0.3784 | USD |
Información Financiera Aligos Therapeutics Inc ALGS
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
29.68M | 78.11M | - | 15.53M | -87.68M | -1.12 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Aligos Therapeutics Inc ALGS
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
05/6/2024 | 01:30 | GlobeNewswire Inc. | Aligos Therapeutics Presents Positive Data at the EASL.. |
31/5/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
22/5/2024 | 15:05 | GlobeNewswire Inc. | Aligos Therapeutics Announces Six Abstracts Accepted for.. |
22/5/2024 | 15:02 | Edgar (US Regulatory) | Form 8-K - Current report |
21/5/2024 | 07:00 | GlobeNewswire Inc. | Aligos Therapeutics Announces the Completion of Enrollment.. |
15/5/2024 | 16:01 | Edgar (US Regulatory) | Form 8-K - Current report |
07/5/2024 | 15:13 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
07/5/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
07/5/2024 | 15:05 | GlobeNewswire Inc. | Aligos Therapeutics Reports Recent Business Progress.. |
30/4/2024 | 15:05 | GlobeNewswire Inc. | Aligos Therapeutics to Announce 1st Quarter 2024 Financial.. |
25/4/2024 | 15:05 | GlobeNewswire Inc. | Aligos Therapeutics Presents Positive Clinical Data at.. |
25/4/2024 | 07:00 | GlobeNewswire Inc. | Aligos Therapeutics Mourns the Passing of MASH Industry.. |
Histórico de Datos ALGS
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.41 | 0.4977 | 0.3658 | 0.4258302 | 645,862 | -0.0316 | -7.71% |
1 Month | 0.61 | 0.6461 | 0.3658 | 0.4814471 | 328,161 | -0.2316 | -37.97% |
3 Months | 1.00 | 1.10 | 0.3658 | 0.6778844 | 280,810 | -0.6216 | -62.16% |
6 Months | 0.745 | 1.20 | 0.3658 | 0.7728174 | 351,516 | -0.3666 | -49.21% |
1 Year | 0.9478 | 1.20 | 0.3658 | 0.7564117 | 245,296 | -0.5694 | -60.08% |
3 Years | 26.79 | 27.1861 | 0.3658 | 3.68 | 265,589 | -26.41 | -98.59% |
5 Years | 14.74 | 37.5099 | 0.3658 | 5.74 | 240,857 | -14.36 | -97.43% |